Related Experiment Video
Updated: Mar 21, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
Human metapneumovirus small hydrophobic (SH) protein downregulates type I IFN pathway signaling by affecting STAT1
Andrew K Hastings1, Katherine R Amato2, Sherry C Wen1
1Department of Pathology, Microbiology & Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, United States.
Abstract:
Type I interferon (IFN) is a key mediator of antiviral immunity. Human metapneumovirus (HMPV) inhibits IFN signaling, but does not encode homologues of known IFN antagonists. We tested the hypothesis that a specific viral protein prevents type I IFN signaling by targeting signal transducer and activator of transcription-1 (STAT1). We found that human airway epithelial cells (capable of expressing IFNs) became impaired for STAT1 phosphorylation even without direct infection due to intrinsic negative feedback. HMPV-infected Vero cells (incapable of expressing IFN) displayed lower STAT1 expression and impaired STAT1 phosphorylation in response to type I IFN treatment compared to mock-infected cells. Transient overexpression of HMPV small hydrophobic (SH) protein significantly inhibited STAT1 phosphorylation and signaling, and recombinant virus lacking SH protein was unable to inhibit STAT1 phosphorylation. Our results indicate a role for the SH protein of HMPV in the downregulation of type I IFN signaling through the targeting of STAT1.
Insights
Human metapneumovirus (HMPV) uses its small hydrophobic (SH) protein to block antiviral immunity. The SH protein inhibits signal transducer and activator of transcription-1 (STAT1) phosphorylation, a key step in interferon signaling.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Type I interferons (IFNs) are crucial for antiviral defense.
- Human metapneumovirus (HMPV) is known to interfere with IFN signaling pathways.
- HMPV lacks known viral antagonists of IFN signaling.
Purpose of the Study:
- To investigate the mechanism by which HMPV inhibits type I IFN signaling.
- To identify the specific viral protein responsible for this inhibition.
- To determine if HMPV targets signal transducer and activator of transcription-1 (STAT1).
Main Methods:
- Comparing STAT1 phosphorylation in HMPV-infected and mock-infected cells.
- Utilizing transient overexpression of HMPV proteins, specifically the small hydrophobic (SH) protein.
- Generating and testing a recombinant HMPV lacking the SH protein.
Main Results:
- HMPV infection impaired STAT1 expression and phosphorylation in response to type I IFN.
- Overexpression of HMPV SH protein significantly inhibited STAT1 phosphorylation and downstream signaling.
- A recombinant HMPV lacking the SH protein failed to inhibit STAT1 phosphorylation.
Conclusions:
- The small hydrophobic (SH) protein of HMPV plays a critical role in downregulating type I IFN signaling.
- HMPV SH protein targets STAT1, thereby inhibiting the antiviral immune response.
- This mechanism represents a novel strategy employed by HMPV to evade host immunity.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
The JAK-STAT Signaling Pathway
Human Virome
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway
Leaky Scanning

